APA (7th ed.) Citation

Jin, J., Wang, L., Wang, X., Lai, P., Huang, M., Jin, D., . . . Bai, X. (2013). Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL/OPG ratio to impair osteoclast differentiation. The Journal of surgical research, 180(1), e21-e29. https://doi.org/10.1016/j.jss.2012.03.018

Chicago Style (17th ed.) Citation

Jin, Jian, Liang Wang, Xiao-kai Wang, Ping-lin Lai, Min-jun Huang, Da-di Jin, Zhao-ming Zhong, Jian-ting Chen, and Xiao-chun Bai. "Risedronate Inhibits Bone Marrow Mesenchymal Stem Cell Adipogenesis and Switches RANKL/OPG Ratio to Impair Osteoclast Differentiation." The Journal of Surgical Research 180, no. 1 (2013): e21-e29. https://doi.org/10.1016/j.jss.2012.03.018.

MLA (9th ed.) Citation

Jin, Jian, et al. "Risedronate Inhibits Bone Marrow Mesenchymal Stem Cell Adipogenesis and Switches RANKL/OPG Ratio to Impair Osteoclast Differentiation." The Journal of Surgical Research, vol. 180, no. 1, 2013, pp. e21-e29, https://doi.org/10.1016/j.jss.2012.03.018.